Health In Tech, Inc.
Datakwaliteit: 100%
HIT
Nasdaq
Financial Services
Insurance Agents & Brokers
€ 1,42
▲
€ 0,06
(4,41%)
Marktkapitalisatie: 93,09 M
Prijs
€ 1,42
Marktkapitalisatie
93,09 M
Dagbereik
€ 1,35 — € 1,44
52-Weeksbereik
€ 0,55 — € 4,02
Volume
42.077
Openen € 1,35
50D / 200D Gem.
€ 1,43
0,38% below
50D / 200D Gem.
€ 1,96
27,52% below
Quick Summary
Belangrijkste Punten
Earnings grew 90,74% over the past year
Generating 3,13 M in free cash flow
P/E of 72,79 — premium valuation
Cash machine — converts 245,05% of earnings into free cash flow
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)70,99%
Earnings (1Y)90,74%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
7,62%
Onder sectorgemiddelde (10,70%)
ROICN/A
Net Margin3,84%
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio2,87
Interest CoverageN/A
Waardering
PE (TTM)
72,79
Boven sectorgemiddelde (12,63)
P/B Ratio5,43
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Financial Services sector mediaan (1096 peers)
Sectorvergelijking
vs Financial Services sector mediaan (1096 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 72,8 | 12,6 |
| P/B | 5,4 | 1,4 |
| ROE % | 7,6 | 10,7 |
| Net Margin % | 3,8 | 14,8 |
| Rev Growth 5Y % | — | 6,4 |
| D/E | — | 0,5 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 70,99% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | 90,74% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 33,33 M | Net Income (TTM) | 1,28 M |
| ROE | 7,62% | ROA | 5,69% |
| Gross Margin | 62,82% | Operating Margin | N/A |
| Net Margin | 3,84% | Free Cash Flow (TTM) | 3,13 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2,87 |
| Interest Coverage | N/A | Asset Turnover | 1,48 |
| Working Capital | 9,81 M | Tangible Book Value | 17,16 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 72,79 | Forward P/E | N/A |
| P/B Ratio | 5,43 | P/S Ratio | 2,79 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 3,37% | ||
| Market Cap | 93,09 M | Enterprise Value | 85,07 M |
| Per Share | |||
| EPS (Diluted TTM) | 0,02 | Revenue / Share | 0,51 |
| FCF / Share | 0,05 | OCF / Share | 0,05 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 245,05% |
| SBC-Adj. FCF | 1,56 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | 33,33 M | 19,49 M |
| Net Income | 1,28 M | 670.477,0 |
| EPS (Diluted) | 0,02 | — |
| Gross Profit | 20,94 M | 15,44 M |
| Operating Income | — | — |
| EBITDA | — | — |
| R&D Expenses | 1,57 M | 2,81 M |
| SG&A Expenses | — | — |
| D&A | 900.577,0 | 541.141,0 |
| Interest Expense | 495.000,0 | 495.000,0 |
| Income Tax | 395.330,0 | 218.523,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Total Assets | 23,09 M | 15,77 M |
| Total Liabilities | 5,98 M | 2,60 M |
| Shareholders' Equity | 17,11 M | 13,17 M |
| Total Debt | — | — |
| Cash & Equivalents | 7,67 M | 7,85 M |
| Current Assets | 16,16 M | 10,78 M |
| Current Liabilities | 5,16 M | 2,13 M |
{"event":"ticker_viewed","properties":{"ticker":"HIT","listing_kind":"stock","pathname":"/stocks/hit","exchange":"Nasdaq","country":"US"}}